Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Results>Dongrui Pharmaceutical (02348.HK) Full-Year Net Profit RMB214 Million, Down 62.1%; Final Dividend HKD4.8 Cents
Recommend 1 Positive 1 Negative 1 |
||||
|
||||
|
Dongrui Pharmaceutical (02348.HK) announced its 2025 annual results, reporting revenue of RMB1.231 billion, representing a year-on-year increase of 16.1%. The company recorded a net profit of RMB214 million, a decline of 62.1%, with earnings per share of RMB0.14. A final dividend of HKD0.048 per share will be distributed. (de/d) Auto-translated by third-party software This translation was auto-generated by third-party software. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
